Sara B Bloch, Michael Larsen. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdolescentAngiogenesis Inhibitors/adverse effectsAngioid Streaks/drug therapyAngioid Streaks/pathologyAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedChoroidal Neovascularization/drug therapyChoroidal Neovascularization/pathologyFemaleFibrosis/etiologyFluorescein AngiographyFovea CentralisHumansIntravitreal InjectionsMacula Lutea/pathologyRanibizumabRetreatmentVascular Endothelial Growth Factor A/antagonists & inhibitors
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedVEGFA protein, humanVascular Endothelial Growth Factor ARanibizumab
Year: 2011 PMID： 20222906 DOI： 10.1111/j.1755-3768.2009.01813.x
Source DB: PubMed Journal: Acta Ophthalmol ISSN： 1755-375X Impact factor: 3.761